Some career moves don’t just change your location. They change how you see everything. Juan Pablo Udry crossed from Argentina into Brazil thinking he understood pharmaceuticals. He had years of experience, a track record that worked, strategies he trusted. Then Brazil showed him how little any of that mattered. The market was massive, yes, but that wasn’t the real shock. What caught him off guard was how different everything operated. Regions that should have been similar weren’t. Customer behaviors he thought he could predict turned unpredictable. Nothing translated the way he expected.
That confusion taught him more than success ever had. Latin America’s pharmaceutical world refuses to stay put. Governments change and healthcare policies flip overnight. What works brilliantly in one place dies quietly in another. The only thing that doesn’t shift is the patients waiting for medicine, regardless of whatever chaos is happening around them.
Today, as CEO of TRB Pharma, Udry runs the company with that lesson baked in. He’s not chasing perfect plans or one-size-fits-all answers. He’s watching people, listening to what markets are actually saying, and building teams who can think on their feet without forgetting what matters.
Let’s explore how Udry’s journey shaped adaptive leadership, human-centered strategy, and a future-focused healthcare vision!
A Start Shaped by Scale
He quickly learned that Brazil cannot be treated as a single unified market. The language is shared, but the cultures across regions are not. Northern cities differ from the South. The Northeast has its own rhythm compared to the Midwest. As Udry describes it, every region presents a different type of customer and a different internal structure in the healthcare ecosystem. Understanding how to build a national strategy that works in multiple regional contexts became one of his first major lessons. It also prepared him for the career he would later have across Latin America, where the diversity of markets is even broader.
During those years, he learned to work across countries where Spanish is spoken differently, where regulations change from border to border, and where consumer behavior does not follow the same patterns. This period reinforced the importance of reading cultural cues, anticipating shifts, and adapting quickly. It also showed him how much political transitions can impact healthcare. Udry states it plainly when he says, “Another big learning was the structural changes in healthcare systems based on political shifts.” Elections can change not only the government but also taxes, incentives, healthcare priorities, and the way companies operate. This taught him to stay alert and ready to adjust every time a new administration comes in.
These early experiences did more than teach him how to manage markets. They shaped the way he approaches leadership today. They broadened his thinking, improved his flexibility, and strengthened his ability to prepare for the unexpected. He says with clarity that these moments “shaped my thinking for future roles, where I later handled regional responsibilities across Latin America.” The variety of challenges and lessons became the structure he still relies on when facing today’s responsibilities.
Growing Into Purpose
When Udry stepped into the role of CEO at TRB Pharma, his personal vision for healthcare took on deeper meaning. He often describes this shift in simple but impactful terms, saying, “Working in healthcare means improving people’s lives every day.” This understanding affects how he builds teams and how he defines the culture he wants to create. He believes strongly that not everyone is motivated by the same mission. Some people want to join a company because they feel connected to the purpose behind the work. Others may not feel the same drive. His goal is to identify those who genuinely want to make a difference in patients’ lives, because they are the ones who create strong teams that work with intention.
He explains that those who believe in improving quality of life, bringing good products to market, and building high-performing organizations are the people who contribute to long-term success. He describes this by saying, “If you’re here to improve people’s quality of life, bring good products to market, and build the best organization possible those are the people who form strong teams with purpose, not just goals.” Purpose, in his view, gives meaning to performance. It brings unity to groups that would otherwise be driven only by individual targets.
Connecting Across Generations
Staying connected to people is a priority for him, but he admits it is more complex today than before. Three generations work under the same roof. Gen X, Millennials, and Gen Z each bring different expectations, motivations, and communication styles. Udry reflects on how his own generation valued long-term loyalty and the desire to stay with a company for many years. Younger generations, however, often think differently. They seek accelerated growth, personal development, and broader experiences. For him, understanding these differences is essential. It allows him to support employees and guide them through short term and long term perspectives.
He believes that motivation comes from clarity. People perform better when they understand what is expected and when they see a path ahead of them. His approach is grounded in conversation. He believes that “The only way to stay connected is to talk to people.” For him, an open-door culture is not symbolic. It is practical. It allows people to speak openly, ask questions, and express ideas. This openness, however, remains respectful and structured. It is freedom to speak, but not freedom to disregard responsibility.
He also values the knowledge that younger generations bring, particularly in areas like artificial intelligence and digital tools. He sees this as an opportunity to learn from them. He understands that leaders cannot navigate the future alone. They need the support and the fresh thinking of those who grew up in a rapidly changing world.
Mentorship Through Attitude
Mentorship is another area where he invests a great deal of attention. He does not define leadership potential by technical knowledge. Instead, he focuses on attitude. He believes that a person’s motivation, openness, and willingness to grow reveal more about their leadership potential than what they know at a given moment. He explains it directly when he says, “Leadership shows in attitude. Knowledge can be taught. Attitude is much harder to develop.” For him, everything else can be trained. The right attitude cannot.
He looks for young professionals who demonstrate initiative and humility. Udry believes that good leaders are not those who know everything, but those who know whom to ask. He models this himself. “If you ask me what I prefer always attitude” expresses his approach clearly. Even in a science-based industry, he does not try to be the scientific expert. Instead, he surrounds himself with people who are experts in their fields. This allows him to lead with clarity and focus while relying on specialists who bring depth in areas where he prefers to listen and learn.
Finding Reward in the Future
One of the most rewarding aspects of his current role is the future. He finds inspiration in what can be built rather than in what already exists. He often expresses this mindset with the phrase, “What drives me today is not what we have now, but what we can build.” TRB Pharma has a strong foundation, but he sees significant opportunity ahead. Even though the Brazilian market is facing a difficult period, he views this as a moment for strategic planning and long-term preparation. He believes in the company’s turnaround strategy and in the potential it holds. He finds motivation in imagining where the company can be five years from now, describing this outlook by saying, “If we do the right things, the dream is achievable.”
Part of that long-term strategy involves a shift in how the company approaches musculoskeletal health. Today, much of the company’s portfolio consists of established products that have served the market well for many years. However, Udry believes that the future requires a broader vision. He describes this clearly by saying, “We want to shift our musculoskeletal strategy from treatment to prevention.” He wants TRB Pharma to play a role earlier in the patient journey. Instead of focusing only on treating pain or dysfunction, he wants to help slow the onset of conditions that naturally occur as people age. Bones, joints, and tendons inevitably weaken over time, but he believes the company can support healthier progression and help people remain active for longer.
A Move Toward Sports Medicine
This shift also connects naturally to another strategic priority for the future. He wants TRB Pharma to become a key reference in sports medicine. Athletes at all levels face issues related to recovery, mobility, and joint health. The company sees an opportunity to provide solutions that help them return to activity faster and maintain performance. His ambition is captured in the statement, “Our goal: be the #1 sports medicine supporter for joints in Brazil.” Earning the trust of elite athletes would strengthen the company’s credibility across the broader athletic community. He recognizes that this will take time, but he sees it as a direction worth pursuing.
Standing Firm in a Challenging Market
Despite these promising goals, the company faces real challenges. One business unit is currently operating in a market with flat growth and intense low-price competition. Products imported from other regions have weakened the market by offering cheaper alternatives that do not match the scientific quality of Swiss-made products. This threatens not only the company’s market share but also the perception of value in the category. Udry explains the situation openly and emphasizes that the company is responding by investing in medical education and scientific evidence. He states with confidence, “We need to prove we are best-in-class and we’re doing that.” He believes that giving physicians firsthand experience with the company’s products and supporting them with strong data will reinforce the difference between premium solutions and copies.
Building a Recognized Name
As he looks toward the long-term legacy he hopes to build, he reflects on a unique reality. Across Latin America, the company’s brands are known, but the company itself is not always recognized. He wants to change that. He hopes that by the time he leaves his role, TRB will be a well-known reference in the region. He expresses this clearly, saying, “When I eventually leave my role, I want TRB to be a known reference in the market.” This aspiration is not about personal recognition. It is about strengthening the reputation of the organization as a whole and building a name that carries trust beyond individual products.
A Final Message of Honesty
Udry also shares a message for his team and for the wider healthcare community. He speaks honestly about growth and the realities of organizational change. He believes that developing a company requires taking the next step, even when not everyone agrees or is prepared to follow. He emphasizes the importance of evaluating whether people can grow with the organization and whether training or changes are needed. He stresses that transparency and clear goals guide people to understand whether they are aligned with the direction of the company. His closing message is marked by clarity when he says, “Don’t fear change.”
Throughout his journey, the focus has remained consistent. From his early experiences in Brazil to his work across Latin America, he has always viewed healthcare as both a responsibility and an opportunity to make a real difference. His leadership at TRB Pharma reflects that perspective. It is grounded in purpose, shaped by people, and strengthened by the belief that the future can be built with clarity and intention.
